BioCentury
ARTICLE | Company News

Amgen to pay $762M for illegal promotion

December 20, 2012 1:32 AM UTC

Amgen Inc. (NASDAQ:AMGN) will pay $612 million to resolve civil liability related to promotional activities for six of its drugs, including anemia drugs Aranesp darbepoetin alfa and Epogen epoetin alf...